IDNA · iShares Genomics Immunology and Healthcare ETF
iShares Trust
$42.58
+3.96%
Intraday · Oct 20
Net assets $190,862,668
Holdings61
1 month
+0.81%
Year to date
+57.06%
52-week range
$24.29–$43.44
30-session avg volume
184,356
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000065599
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings49.51%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC96.02%
STIV10.49%
DE0.01%
Country allocation
US70.15%
DE8.54%
FR7.76%
JP6.00%
CH5.41%
DK4.24%
GB3.66%
Other4.57%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | $19,834,626 | 10.39% |
| Bayer Aktiengesellschaft | $9,184,987 | 4.81% | |
| Twist Bioscience Corp | TWST | $9,149,232 | 4.79% |
| REVOLUTION MEDICINES, INC. | RVMD | $8,692,391 | 4.55% |
| REGENERON PHARMACEUTICALS, INC. | REGN | $8,302,753 | 4.35% |
| GENMAB A/S | $8,079,336 | 4.23% | |
| INCYTE CORPORATION | INCY | $8,075,966 | 4.23% |
| MODERNA, INC. | MRNA | $7,993,798 | 4.19% |
| Takeda Pharmaceutical Company Limited | $7,728,949 | 4.05% | |
| MERCK & CO., INC. | MRK | $7,456,554 | 3.91% |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | $7,385,985 | 3.87% |
| Roche Holding AG | $7,341,404 | 3.85% | |
| IPSEN SA | $7,328,654 | 3.84% | |
| BioNTech SE | BNTX | $7,114,153 | 3.73% |
| EXELIXIS, INC. | EXEL | $6,961,513 | 3.65% |
| GSK PLC | $6,934,182 | 3.63% | |
| SANOFI SA | $6,612,342 | 3.46% | |
| IDEAYA Biosciences Inc | IDYA | $6,407,147 | 3.36% |
| Immunitybio Inc | IBRX | $5,859,202 | 3.07% |
| ARCUS BIOSCIENCES, INC. | RCUS | $5,123,899 | 2.68% |
| CARIS LIFE SCIENCES, INC. | CAI | $4,170,335 | 2.18% |
| ONO PHARMACEUTICAL CO., LTD. | $3,654,051 | 1.91% | |
| Iovance Biotherapeutics Inc | IOVA | $3,426,248 | 1.80% |
| NUVATION BIO INC. | NUVB | $3,394,659 | 1.78% |
| CRISPR Therapeutics AG | CRSP | $2,987,234 | 1.57% |
| ABCELLERA BIOLOGICS INC. | ABCL | $2,906,019 | 1.52% |
| Vir Biotechnology Inc | VIR | $2,505,035 | 1.31% |
| NOVAVAX, INC. | NVAX | $2,486,187 | 1.30% |
| Janux Therapeutics Inc | JANX | $1,883,598 | 0.99% |
| Sunshine Lake Pharma Co Ltd | Y8243F109 | $1,874,392 | 0.98% |
| Corvus Pharmaceuticals Inc | CRVS | $1,817,933 | 0.95% |
| Personalis Inc | PSNL | $1,702,504 | 0.89% |
| Kura Oncology Inc | KURA | $1,679,896 | 0.88% |
| GenFleet Therapeutics (Shanghai) Inc | Y2S2YD109 | $1,480,868 | 0.78% |
| RIGEL PHARMACEUTICALS, INC. | RIGL | $1,428,486 | 0.75% |
| CytomX Therapeutics Inc | CTMX | $1,165,315 | 0.61% |
| VERASTEM, INC. | VSTM | $1,036,570 | 0.54% |
| Alvotech SA | ALVO | $1,008,988 | 0.53% |
| Design Therapeutics Inc | DSGN | $996,421 | 0.52% |
| Xencor Inc | XNCR | $983,641 | 0.52% |
| INTELLIA THERAPEUTICS, INC. | NTLA | $981,364 | 0.51% |
| Shanghai Henlius Biotech Inc | $964,127 | 0.51% | |
| OCUGEN, INC. | OCGN | $890,253 | 0.47% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACB | $870,867 | 0.46% |
| VALNEVA SE | $866,333 | 0.45% | |
| Ginkgo Bioworks Holdings Inc | DNA | $819,711 | 0.43% |
| AbClon Inc. | Y0R0KQ104 | $469,839 | 0.25% |
| Prime Medicine, Inc | PRME | $191,202 | 0.10% |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | $177,863 | 0.09% |
| JAPANESE YEN | $71,568 | 0.04% |
Showing the top 50 of 61 holdings. Create a free account to see every holding and download the CSV.